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Editorial 
Guidelines in asthma 
In 1989 and 1990, four sets of guidelines for 
managing asthma were published (l-4). The first, 
produced by a group of respiratory specialists from 
Australia and New Zealand (1) gave advice on the 
management of chronic asthma. In the same year, an 
international group of respiratory paediatricians 
published advice on the management of asthma in 
children (2). In the following year, the first British 
Guidelines were published in the British Medical 
Journal as two papers on the management of chronic 
persistent asthma (3) and of acute severe asthma (4) 
in adults. These were supported by five fully- 
referenced background papers published in 
Respiratory Medicine (5-9). Also in 1990, a Canadian 
group supported by respiratory specialists from 
Australia and Britain published fully-referenced 
guidelines on managing both acute and chronic 
asthma in adults and children (10). Since 1990, 
asthma guidelines have been published in many other 
countries, including an international consensus 
report on the diagnosis and management of asthma 
(11). Only two of these sets of guidelines have been 
revised, namely the International Paediatric Guide- 
lines (12) and the British Guidelines (13) (twice). This 
editorial will briefly review the processes involved in 
producing the British Guidelines, and their use in the 
management of asthma and in auditing the manage- 
ment of asthma in Britain, and will look ahead to 
how further revisions might be developed in the 
future. 
The processes involved in producing the first 
British Guidelines in 1990, the first revision in 
1992-93 and the second revision in 1995-96 were 
similar and have been described fully (14). Briefly, a 
number of chest physicians (including academic, 
teaching hospital and district general hospital con- 
sultants), general physicians, general practitioners 
and, in 1992 and 1995, paediatricians were invited to 
participate. As well as being intended to encompass 
the range from academic to district general hospital 
practice, chest physicians were chosen to reflect the 
geographical and age ranges of respiratory medical 
practitioners in Great Britain. In 1992 and 1995, 
participants represented nine British societies, col- 
leges, associations and groups involved in asthma 
care. Colleagues, selected because of their particular 
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expertise, were asked to prepare draft, succinct state- 
ments on topics to be included in the Guidelines, 
together with more extensive, fully-referenced back- 
ground papers (5-9) designed to support those in- 
evitably didactic statements. The statement and 
background papers were reviewed by all participants 
and, where appropriate, suggested changes were 
made in the draft statements which were than incor- 
porated into draft Guidelines. These were discussed 
in small groups and in a plenary session of all 
participants during a 2-day meeting at which the final 
draft Guidelines were agreed. In 1990, this final draft 
was circulated to all members of the British 
Thoracic Society (BTS) with a questionnaire, and 
then presented to a meeting of over 300 members 
of the BTS at the annual summer meeting. The 
questionnaire responses from 357 chest physicians 
indicated that over 80% thought the Guidelines 
were appropriate, acceptable and achievable. Final 
modifications were made and the Guidelines were 
submitted for publication in the British Medical 
Journal (3,4). 
There were four reasons for reviewing the British 
Guidelines in 1992. The first two reasons concerned 
P-agonists. Controversy regarding the safety of 
regular B-agonist therapy was raised by the publi- 
cation of two papers (15,16) later in 1990 and in 1991, 
and there was concern over the role of long-acting 
inhaled P-agonists which became available after the 
publication of the 1990 Guidelines. The other two 
reasons arose from criticisms which had been levelled 
at the 1990 Guidelines. First, they did not include 
the management of asthma in children [deliberately 
excluded because of the recent publication of the 
International Guidelines (2)], and secondly, they were 
too long and, although published in a widely read 
general medical journal (3,4), were not particularly 
user-friendly. The revised Guidelines (13) included 
advice on the management of asthma in children, and 
also six single-page charts which summarized the 
advice for adults and children and which were 
designed for use in the general practice or hospital 
outpatient consultation setting, the medical ad- 
mission unit or medical wards of an acute hospital, 
and the accident and emergency department. No 
background papers were published to accompany 
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the 1993 Guidelines, but areas of uncertainty or 
controversy were highlighted. In 1995, a second 
revision of the British Guidelines was undertaken 
using identical processes, but this time it was felt 
that there was insufficient new data to justify a full 
revision, though enough to warrant a paper which 
would act as a commentary on the 1993 Guidelines. 
This paper has been submitted for publication and 
eight of the background papers are to be published in 
this issue and the next issue of Respiratory Medicine 
(17-24). 
The British Guidelines have always been based on 
evidence coupled, where there was no evidence, with 
agreed current practice. The evidence was collated by 
experts in each field and presented in the form of 
‘state-of-the-art’ papers (5-9). These were reviewed 
critically by the .peers who participated in the 
Guidelines’ process, some of whom were equally 
renowned experts in the several fields included. This 
process is more akin to state-of-the-art review than 
that favoured by some guidelines’ authorities (25,26), 
where recommendations are graded according to the 
type of published evidence used, namely: 
Grade A, Guidelines based on well-designed random- 
ized controlled trials or meta-analysis; 
Grade B, Evidence based on well-designed cohort or 
case controlled studies; and 
Grade C, Recommendations based on uncontrolled 
studies or consensus. 
Interestingly, the results of guidelines produced in 
these different ways are very similar. We need more 
information on the relative costs and effectiveness 
of guidelines produced by these approaches before 
we can judge which is preferable for a particular 
condition. 
How effective have the British Guidelines been? 
The answer to this in terms of outcome of asthma 
remains unknown, although guidelines in other con- 
ditions have been effective (27). We do know that 
over 75% of general practitioners (GPs) covering a 
population of half a million people have read the 
Guidelines and found them useful (28). In a national 
survey of 206 GPs, 78% were quite or very familiar 
with the 1993 Guidelines and 70% had changed how 
they manage asthma as a result of those Guidelines 
(29). One of the initial aims of the British Guidelines, 
which has been amply achieved, was that they should 
be usable as a standard for auditing the processes 
and outcomes of asthma care. Since 1990 there 
have been many papers presented at the annual 
meetings of the British Thoracic Society auditing 
asthma care in Britain, and indeed overseas, using the 
British Guidelines, including two national studies of 
inpatient care of asthma (30,31) and an ongoing 
confidential enquiry into asthma deaths in six regions 
of Britain. Many groups have produced local guide- 
lines for general or hospital practice or both, or 
local protocols based on the National Guidelines. 
There is a widespread view amongst GPs and 
hospital doctors that the Asthma Guidelines have 
improved the management of asthma in Britain. 
Whilst asthma prevalence is rising (32), asthma 
deaths are falling (33) and it is possible that the 
Guidelines have contributed to this improvement 
in mortality. 
Barnes, in his paper on inhaled glucocorticoids 
(17) discusses the roles of fluticasone propionate and 
nebulized budesonide in the management of chronic 
asthma. He also recommends earlier treatment with 
inhaled steroids, and starting treatment with higher 
doses of inhaled steroids followed by dose reduction 
when asthma control is achieved, rather than increas- 
ing the dose progressively until control is achieved. In 
other words, treatment should be started with a dose 
of inhaled steroid likely to bring the asthma under 
control rapidly. 
Neville, in his paper on patient education and 
guided self-management plans (18) emphasizes 
that education by itself, whilst increasing patients’ 
knowledge, does not improve morbidity due to 
asthma. Written self-management plans based on 
recommending changes of treatment as symptoms 
and peak flows increase or decrease, do work and are 
to be commended. 
Holgate reviews the evidence for the efficacy and 
positioning of inhaled sodium cromoglycate (19) and 
inhaled nedocromil sodium (20). The recommen- 
dations for their use in the 1996 Guidelines remain 
identical to those recommended in 1993. 
In his paper on allergen avoidance measures (21), 
Durham concludes that the patients likely to benefit 
from these can be recognized from the clinical history 
and simple skin prick test, and that proven methods 
exist for avoidance of house dust mite with bedding 
barrier materials, regular hot washing of bed clothes 
(60”(Z), removal of bedroom carpets, and regular 
dusting and vacuuming with an efficient cleaner. 
Patients with pet sensitivities should be advised 
regarding the removal of the pet, non-replacement of 
the pet when it dies, or exclusion of the pet from the 
bedroom and, ideally, from indoors. Occupational 
causes of asthma should always be sought in adults, 
and active and passive smoking should always be 
discouraged. 
Bucknall considers definitions of asthma severity 
and outcome measures in her review (22). Severity 
scores based on symptom control, physiological 
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measurements expressed as a percentage of best func- 
tion and treatment (current BTS step) are being 
evaluated. Outcome for ambulatory care could use 
the same measures, and, to date, the most widely 
accepted is the physiological outcome measure of 
percentage of best function of either peak flow or 
FEV,, which corrects for the degree of irreversible 
airflow obstruction and is independent of treatment 
step. For inpatient outcomes, re-admission rates 
show promise, but they also relate to the quality of 
discharge planning as well as the severity of asthma. 
As a result of national audits of inpatient asthma 
care, using the earlier BTS Guidelines as standards, 
Pearson et al. (31) have suggested eight process 
measures which deserve further study. 
In their paper on psychosocial factors in asthma 
(23), Bosley et al. address an area of considerable 
importance to which many pay lip service, but in 
which there is a dearth of high-quality research. 
Studies in the northern and southern hemispheres 
have shown that the majority of patients dying from 
asthma, and the majority of those suffering near-fatal 
attacks of asthma, suffer from or experience major 
psychological or social adversity. Similar factors 
occur in the lives of many patients with brittle asthma 
(34) and those exhibiting poor compliance with their 
therapy. In addition to material poverty, denial, 
depression, anxiety and other psychiatric illness have 
been highlighted as very important factors. Life 
crises, family conflict, increased social isolation, 
shame, anger, smoking, alcohol or drug abuse are 
also probably important. More studies in these 
important fields are required urgently. 
In the paper on recommendations for peak flow 
monitoring in children (24), Clough highlights the 
pitfalls and precautions necessary to ensure that 
readings are meaningful and useful, points equally 
applicable to peak flow monitoring in adults. In 
particular, she emphasizes that manufacturers should 
take steps to adjust for non-linearity by adjustment 
of scale, and that manufacturers and regulatory 
bodies should agree upon the standards for accuracy, 
comparability and repeatability of different meters. 
In summary, representatives from all groups of 
doctors involved in the care of patients with asthma 
have been involved in developing the British Guide- 
lines. The Guidelines are extremely practical, and 
indeed practicable, and they have not been handed 
down from ‘on high’ by a small group of ‘experts’. 
They are based on published evidence, where this is 
available, which is presented in the form of ‘state-of- 
the-art’ reviews (5%9,17-24). These are the factors 
which have led to their wide acceptance and use, 
but more work is needed to determine the optimal 
methods of dissemination of asthma guidelines and 
to determine their effects on outcomes. 
B. D. W. HARRISON 
Department of Respiratory Medicine 
Norfolk and Norwich Hospital 
Norwich, U.K. 
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